Free Trial

SAB Biotherapeutics (SABSW) Competitors

$0.08 -0.05 (-40.30%)
As of 01/14/2025 03:49 PM Eastern

SABSW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ACABW, BFRIW, BTMDW, BCTXW, and CELUW

Should you be buying SAB Biotherapeutics stock or one of its competitors? The main competitors of SAB Biotherapeutics include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), BriaCell Therapeutics (BCTXW), and Celularity (CELUW). These companies are all part of the "pharmaceutical products" industry.

SAB Biotherapeutics vs.

180 Life Sciences (NASDAQ:ATNFW) and SAB Biotherapeutics (NASDAQ:SABSW) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, community ranking, profitability, earnings, dividends, media sentiment, valuation, risk and institutional ownership.

Company Net Margins Return on Equity Return on Assets
180 Life SciencesN/A N/A N/A
SAB Biotherapeutics N/A N/A N/A

180 Life Sciences and SAB Biotherapeutics both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
180 Life SciencesN/AN/A
SAB BiotherapeuticsN/AN/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
180 Life SciencesN/AN/AN/AN/AN/A
SAB Biotherapeutics-$11.22MN/AN/AN/AN/A

In the previous week, SAB Biotherapeutics had 1 more articles in the media than 180 Life Sciences. MarketBeat recorded 2 mentions for SAB Biotherapeutics and 1 mentions for 180 Life Sciences. 180 Life Sciences' average media sentiment score of 1.89 beat SAB Biotherapeutics' score of 0.92 indicating that 180 Life Sciences is being referred to more favorably in the media.

Company Overall Sentiment
180 Life Sciences Very Positive
SAB Biotherapeutics Positive

Summary

180 Life Sciences beats SAB Biotherapeutics on 2 of the 3 factors compared between the two stocks.

Get SAB Biotherapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for SABSW and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SABSW vs. The Competition

MetricSAB BiotherapeuticsBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$175.32M$5.25B$8.80B
Dividend YieldN/A3.64%5.07%4.00%
P/E RatioN/A126.0188.2616.96
Price / SalesN/A18,896.731,112.76123.64
Price / CashN/A13.0143.2137.77
Price / BookN/A9.435.054.89
Net IncomeN/A-$20.89M$122.32M$228.40M
7 Day PerformanceN/A1.41%-2.86%-2.25%
1 Month PerformanceN/A1.66%-1.04%-0.41%
1 Year PerformanceN/A149.47%22.94%13.53%

SAB Biotherapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SABSW
SAB Biotherapeutics
N/A$0.08
-40.3%
N/A+166.7%$0.00$-11,221,976.000.00140Short Interest ↑
ATNFW
180 Life Sciences
N/A$0.01
+2.9%
N/A+80.7%$0.00N/A0.007Positive News
Gap Down
High Trading Volume
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522,000.000.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.03
-2.7%
N/A+6.6%$0.00N/A0.002Gap Up
High Trading Volume
AIMDW
Ainos
N/A$0.14
+164.7%
N/AN/A$0.00$40,633.000.0040Positive News
High Trading Volume
ALVOW
Alvotech
N/A$3.30
+6.1%
N/A+15.6%$0.00$391.87M0.004Positive News
Gap Down
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.09
+4.2%
N/AN/A$0.00N/A0.004Gap Up
BFRIW
Biofrontera
N/A$0.07
+1.4%
N/AN/A$0.00$35.36M0.0070Positive News
BTMDW
biote
N/A$0.45
flat
N/AN/A$0.00$193.06M0.00N/A
BCTXW
BriaCell Therapeutics
N/A$0.24
-29.9%
N/A-91.6%$0.00N/A0.008Short Interest ↑
Positive News
Gap Down
CELUW
Celularity
N/A$0.02
+1.0%
N/A+60.7%$0.00$48.20M0.00220Positive News

Related Companies and Tools


This page (NASDAQ:SABSW) was last updated on 1/15/2025 by MarketBeat.com Staff
From Our Partners